Express (EXPR) Tops Q4 EPS by 16c

Express (NYSE: EXPR) reported Q4 EPS of ($0.66), $0.16 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $430.3 million versus the consensus estimate of $424.7 million.

Full Year 2021 Outlook:

Due to the uncertainty of the current environment, the Company will only provide a high level outlook for 2021. For the full year of 2021, the Company expects the following:

• Sequential comparable sales improvement throughout the year
• Significant gross margin improvement for the year
• Buying & Occupancy expense dollars to decrease double digits as a percent to 2019
• SG&A expense dollars to decrease high single digits as a percent to 2019
• Positive operating cash flow for the year
• Positive EBITDA for the second half of the year
• Capital expenditures of approximately $35 million

Assumptions in the Company outlook are dependent upon the duration and intensity of the COVID-19 pandemic.

For earnings history and earnings-related data on Express (EXPR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c